Literature DB >> 10980817

Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.

T H LeJemtel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10980817     DOI： 10.1007/s11886-999-0038-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  3 in total

1.  Inotropic therapy for heart failure.

Authors:  L W Stevenson
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

2.  A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.

Authors:  J N Cohn; S O Goldstein; B H Greenberg; B H Lorell; R C Bourge; B E Jaski; S O Gottlieb; F McGrew; D L DeMets; B G White
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

3.  Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol.

Authors:  E J Eichhorn; C M Heesch; R C Risser; L Marcoux; B Hatfield
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.